Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
 <li>
Dominant Market Position: <a href="https://smartkarma.com/entities/jd-health-international-inc">JD Health</a> International Inc. (6618 HK) is China's largest online healthcare platform and digital pharmacy by revenue, delivering RMB 79.65 billion in FY2025 revenue with an expanding gross margin of 24.78% and net profit of RMB 5.83 billion.</li>
 <li>
Supply Chain and Fulfillment Moat: Backed by parent JD.com's nation-leading logistics and proprietary pharmaceutical cold-chain infrastructure, <a href="https://smartkarma.com/entities/jd-health-international-inc">JD Health</a> maintains a defensible operational moat over digital and offline retail peers in direct pharmaceutical distribution (1P) and platform services (3P).</li>
 <li>
Operating Leverage and Cash Generation: The business demonstrates compounding operating leverage, with net margin expanding from 4.00% in FY2023 to 7.32% in FY2025 and free cash flow reaching RMB 10.86 billion, providing robust balance sheet flexibility for strategic growth and share repurchases.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  
Dominant Market Position: JD Health International Inc. (6618 HK) is China's largest online healthcare platform and digital pharmacy by revenue, delivering RMB 79.65 billion in FY2025 revenue with an expanding gross margin of 24.78% and net profit of RMB 5.83 billion.
  
Supply Chain and Fulfillment Moat: Backed by parent JD.com's nation-leading logistics and proprietary pharmaceutical cold-chain infrastructure, JD Health maintains a defensible operational moat over digital and offline retail peers in direct pharmaceutical distribution (1P) and platform services (3P).
  
Operating Leverage and Cash Generation: The business demonstrates compounding operating leverage, with net margin expanding from 4.00% in FY2023 to 7.32% in FY2025 and free cash flow reaching RMB 10.86 billion, providing robust balance sheet flexibility for strategic growth and share repurchases.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

China

JD Health International Inc. is a Chinese online healthcare platform and retail pharmacy. It provides pharmaceutical and healthcare products, internet healthcare services, health management, and intelligent healthcare solutions. The company was founded in February 2014 and is headquartered in Beijing, China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

JD Health (6618 HK)

Primer: JD Health (6618 HK) - Oct 2026

Dominant Market Position: JD Health International Inc. (6618 HK) is China's largest online healthcare platform and digital pharmacy by revenue,...

αSK Primers

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)